Cargando…
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
Intracranial malignancies, such as primary brain cancers and brain-localized metastases derived from peripheral cancers, are particularly difficult to treat with therapeutic agents, because the blood-brain barrier (BBB) effectively minimizes brain entry of the vast majority of agents arriving from t...
Autores principales: | Chen, Thomas C., da Fonseca, Clovis O., Schönthal, Axel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321279/ https://www.ncbi.nlm.nih.gov/pubmed/30563210 http://dx.doi.org/10.3390/ijms19123905 |
Ejemplares similares
-
Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020) -
The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers
por: Chen, Thomas C., et al.
Publicado: (2021) -
Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases
por: Chen, Thomas C., et al.
Publicado: (2016) -
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol
por: Fonseca, Clovis Orlando da, et al.
Publicado: (2008) -
Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas
por: da Fonseca, Clovis Orlando, et al.
Publicado: (2016)